122 related articles for article (PubMed ID: 6397877)
1. Enzyme immunoassay for serum 18-hydroxycorticosterone and its clinical application.
Watanabe F; Ryota T; Kobayashi Y
Steroids; 1984 May; 43(5):509-16. PubMed ID: 6397877
[TBL] [Abstract][Full Text] [Related]
2. [Enzyme immunoassay for serum 18-hydroxycorticosterone and its clinical application].
Watanabe F; Ryota T; Yamanaga H; Kobayashi Y; Ogihara T; Saeki S; Kumahara Y
Nihon Naibunpi Gakkai Zasshi; 1985 Oct; 61(10):1157-66. PubMed ID: 3002875
[TBL] [Abstract][Full Text] [Related]
3. The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels.
Kem DC; Tang K; Hanson CS; Brown RD; Painton R; Weinberger MH; Hollifield JW
J Clin Endocrinol Metab; 1985 Jan; 60(1):67-73. PubMed ID: 3964794
[TBL] [Abstract][Full Text] [Related]
4. The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
Biglieri EG; Schambelan M
J Clin Endocrinol Metab; 1979 Jul; 49(1):87-91. PubMed ID: 447820
[TBL] [Abstract][Full Text] [Related]
5. 18-Hydroxycorticosterone as a marker for primary hyperaldosteronism.
Lapworth R; Short F; James VH
Ann Clin Biochem; 1989 May; 26 ( Pt 3)():227-32. PubMed ID: 2669615
[TBL] [Abstract][Full Text] [Related]
6. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
Uchida K; Kigoshi T; Iwasaki R; Morimoto S
Jpn J Med; 1989; 28(4):446-51. PubMed ID: 2554039
[TBL] [Abstract][Full Text] [Related]
7. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
[TBL] [Abstract][Full Text] [Related]
8. Adrenal adenoma with 18-hydroxycorticosterone excess and hypertension: a variant of aldosteronomas.
Kigoshi T; Imaizumi N; Azukizawa S; Yamamoto I; Hosojima H; Uchida K; Morimoto S
Horm Res; 1984; 19(4):224-31. PubMed ID: 6745843
[TBL] [Abstract][Full Text] [Related]
9. [In vivo and in vitro studies on 18-hydroxy-11-deoxycorticosterone and 18-hydroxycorticosterone in normal subjects and in those with various adrenocortical disorders (author's transl)].
Ojima M; Kambegawa A
Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):994-1006. PubMed ID: 226427
[TBL] [Abstract][Full Text] [Related]
10. Distinctive plasma aldosterone, 18-hydroxycorticosterone, and 18-hydroxydeoxycorticosterone profile in the 21-, 17 alpha-, and 11 beta-hydroxylase deficiency types of congenital adrenal hyperplasia.
Kater CE; Biglieri EG
Am J Med; 1983 Jul; 75(1):43-8. PubMed ID: 6602548
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of 18-hydroxy-11-deoxycorticosterone and 18-hydroxycorticosterone simultaneously measured in normal subjects and adrenocortical disorders.
Ojima M; Kambegawa A
Tohoku J Exp Med; 1980 Sep; 132(1):75-85. PubMed ID: 7209971
[TBL] [Abstract][Full Text] [Related]
12. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Miyamori I; Yasuhara S; Matsubara T; Okamoto S; Ikeda M; Koshida H; Morise T; Takeda Y; Takeda R; Vecsei P
Endocrinol Jpn; 1987 Dec; 34(6):809-19. PubMed ID: 2836182
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of serum and urinary 18-hydroxycorticosterone analysis in endocrine tests of the adrenal cortex].
Minato M; Honda M; Hatano M
Nihon Rinsho; 1989 Dec; 48 Suppl():1227-30. PubMed ID: 2560070
[No Abstract] [Full Text] [Related]
14. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism.
Fraser R; Beretta-Piccoli C; Brown JJ; Cumming AM; Lever AF; Mason PA; Morton JJ; Robertson JI
Hypertension; 1981; 3(3 Pt 2):I87-92. PubMed ID: 7262982
[TBL] [Abstract][Full Text] [Related]
15. [18-hydroxycorticosterone (18-OH -B)].
Izumi Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():322-7. PubMed ID: 16149520
[No Abstract] [Full Text] [Related]
16. Synthesis of 19-nor-aldosterone, 18-hydroxy-19-nor-corticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma.
Takeda Y; Lewicka S; Koch S; Bige K; Vecsei P; Abdelhamid S; Cojocaru M; Harnik M
J Steroid Biochem Mol Biol; 1990 Nov; 37(4):599-604. PubMed ID: 2278845
[TBL] [Abstract][Full Text] [Related]
17. The unique patterns of plasma aldosterone and 18-hydroxycorticosterone concentrations in the 17 alpha-hydroxylase deficiency syndrome.
Kater CE; Biglieri EG; Brust N; Chang B; Hirai J
J Clin Endocrinol Metab; 1982 Aug; 55(2):295-302. PubMed ID: 7045152
[No Abstract] [Full Text] [Related]
18. Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
Guthrie GP
J Lab Clin Med; 1981 Sep; 98(3):364-73. PubMed ID: 6267148
[TBL] [Abstract][Full Text] [Related]
19. The development and application of a radioimmunoassay for 18-hydroxy-corticosterone.
Martin VI; Edwards CR; Biglieri EG; Vinson GP; Bartter FC
Steroids; 1975 Nov; 26(5):591-604. PubMed ID: 1209688
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of antisera to 18-hydroxycorticosterone and 18-hydroxy-11-deoxycorticosterone and radioimmunoassay for serum 18-hydroxycorticosterone.
Belkien L; Schöneshöfer M; Oelkers W
Steroids; 1980 Apr; 35(4):427-37. PubMed ID: 7376229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
